Institution for Experimental Pathology, University of Iceland, Keldur

Other links:

The University of Iceland.

Reykjavik University
Iceland's largest private university

ORF Genetics
ORF Genetics is effectively pioneering an innovative, unique approach in the manufacturing of growth factors and hard-to-produce recombinant proteins, bypassing the use of bacterial or animal cell systems


Employs highly competent team of qualified experts in designing and producing micro-electronics based sensors and related equipment for research and industrial use.


Actavis is one of the world's leading players in the development, manufacture, and sale of first-class generic pharmaceuticals


Determined to restore maximum biological function to those in need, Össur has more than thirty years’ experience in the design and production of high-tech orthopaedic devices. Our newest platform is Bionic Technology by Össur - a precise fusion of artificial intelligence and human physiology that is transforming the technological landscape


The Innovation Center
Offers collaboration in R&D projects and provides service in its fields expertise. General lab facilities, and equipment such as FE-SEM, AFM, and X-ray computed tomography instrument (nanotom) are available. National and international projects in the field of regenerative medicine and biomaterials, e.g., development of materials for bone regeneration, and improvement of biocompatibility and bioactivity of medical devices.
Contact: Dr. Gissur Örlygsson, This email address is being protected from spambots. You need JavaScript enabled to view it.


Genis is a biomedical development company located in Iceland, focusing on inflammation and tissue regeneration.
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.


Saga Medica
SagaMedica ehf. Is an Icelandic company, established in June 2000. Its aim is to develop, produce and market high quality, natural products, made from Icelandic medicinal herbs.


Kerecis developt products to treat chronic wounds and for abdominal wall reconstruction. A patent pending fish skin derived material improves upon current human and porcine technologies through improved economics and clinical performance, reduced disease transfer risk and absence of cultural constraints on usage.